BioPharm, L.L.C.
Insider
First SEC filing: Nov. 14, 2006 · Latest: Nov. 14, 2006
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2010 | EBS | J | 700,000 | · | · | 2,265,043 Direct | -23.61% | Disposed | (price as of 2026-10-05) |
| May 29, 2009 | EBS | J | 700,000 | · | · | 2,965,043 Direct | -19.10% | Disposed | (price as of 2026-10-05) |
| April 16, 2008 | EBS | J | 400,000 | · | · | 3,665,043 Direct | -9.84% | Disposed | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 14, 2006 | EBS | Common Stock | 4,065,043 | Direct |